CDIP Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

CDIP Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 16 amino acids near the center of human CDIP.

  Source: Synthetic

  (Accession #: NP_037531)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: CDIP1
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76993.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for CDIP Antibody Blocking Peptide

• CDIP
• cell death inducing protein
• Cell death-inducing protein
• chromosome 16 open reading frame 5
• I1
• LITAF-like protein
• Transmembrane protein I1

Background

CDIP, Cell Death Involved p53-target (also known as LITAF-like protein), induces apoptosis. The CDIP gene is upregulated by p53, and CDIP is an effector of p53-dependent apoptosis, but this proceeds via caspase-8 cleavage and TNF-alpha; it is therefore a link between the intrinsic and extrinsic pathways of apoptosis.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: CDIP1